News &
Notifications

Home 9 Newsroom ( Page 54 )

Newsroom

Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network.
With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.

 

Here, you can go directly to the respective years of Investor Relations News:

<span id=February 21, 2019 | Dermapharm continues to drive development of new products" width="0" height="0" data-ratio="1"/>

| Dermapharm continues to drive development of new products

Grünwald, February 21, 2019 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas in Germany, has launched the products Azedil® and Momekort® in Germany just in time for the hay fever season. In addition, the patented medical product bite away® from the 2018 Hyperthermia range has performed well in all sales channels.

CONTACT

Accept Privacy Policy

DIRECTION